[Summary] Research and development of new drugs for major diseases such as malig
RemeGen Co., Ltd. (Yantai) was jointly founded in 2008 by Rongchang Pharmaceutical and Professor Fang Jianmin, a Chinese scientist who studied in the United States. Its headquarters is located in the Yantai area of the China (Shandong) Pilot Free Trade Zone—Yantai Economic and Technological Development Zone, with R&D centers and branches in Beijing, Shanghai, San Francisco, and Washington. On November 9, 2020, RemeGen was listed on the Hong Kong Stock Exchange (RemeGen-B: 09995.HK), raising a total of approximately 590 million US dollars.
RemeGen is committed to discovering, developing, and commercializing original biological drugs with independent intellectual property rights, creating a series of innovative biological drugs of significant clinical value for diseases such as autoimmune, oncology, and ophthalmology. After over a decade of development and accumulation, RemeGen has completed a global layout from early drug discovery, preclinical research, to clinical development and registration. With Dr. Fang Jianmin as the core, the company has built a new drug R&D and registration team of over a thousand people, forming a scientific research and development capability of international first-class level.
What does RemeGen Co., Ltd. (Yantai) require? Who is RemeGen hiring? RemeGen recruitment: 销售类占比最多占52%，其次是医疗卫生/美容保健类占29.5%. What education can get in at RemeGen? 本科占比最多占68.8%，其次是大专占13%. High education required at RemeGen? 硕士占13%，博士占2%. Work experience required at RemeGen? 1-3年占比最多占41.6%，其次是不限占25.8%. Where are the job locations at RemeGen? 北京占比最多占15%，其次是烟台占11.2%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
